FDA takes aim at telehealth companies for promoting unofficial weight loss drug dupes Health Sep 17, 2025 11:16 AM EDT

WASHINGTON (AP) — For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs — including popular weight loss medications — as part of the Trump administration’s crackdown on pharmaceutical advertising.

The Food and Drug Administration on Tuesday posted more than 100 letters to various drugmakers and online prescribing companies, including Hims & Hers, which has built a multibillion-dollar business centered around lower-cost versions of blockbuster obesity injections.

READ MORE: In the gray world of GLP-1 supplements online, health experts urge caution

The FDA warned the company to remove “f

See Full Page